Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in J Gen Virol

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    June 2018
  1. SLON CAMPOS JL, Poggianella M, Burrone OR
    Long-term stability of antibody responses elicited by Dengue virus envelope DIII-based DNA vaccines.
    J Gen Virol. 2018 Jun 20. doi: 10.1099/jgv.0.001094.
    PubMed     Text format     Abstract available


  2. NEROME K, Yamaguchi R, Fuke N, Izzati UZ, et al
    Development of a Japanese encephalitis virus genotype V virus-like particle vaccine in silkworms.
    J Gen Virol. 2018 Jun 7. doi: 10.1099/jgv.0.001081.
    PubMed     Text format     Abstract available


    April 2018
  3. LUTEIJN RD, Drexler I, Smith GL, Lebbink RJ, et al
    Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol.
    J Gen Virol. 2018 Apr 20. doi: 10.1099/jgv.0.001034.
    PubMed     Text format     Abstract available


    February 2018
  4. BISWAS S, Smith GL, Roy EJ, Ward B, et al
    A comparison of the effect of molluscum contagiosum virus MC159 and MC160 proteins on vaccinia virus virulence in intranasal and intradermal infection routes.
    J Gen Virol. 2018;99:246-252.
    PubMed     Text format     Abstract available


    January 2018
  5. SUBRAMANIAM S, Yugo DM, Heffron CL, Rogers AJ, et al
    Vaccination of sows with a dendritic cell-targeted porcine epidemic diarrhea virus S1 protein-based candidate vaccine reduced viral shedding but exacerbated gross pathological lesions in suckling neonatal piglets.
    J Gen Virol. 2018 Jan 4. doi: 10.1099/jgv.0.001001.
    PubMed     Text format     Abstract available


    November 2017
  6. YU Q, Liu Y, Du J, Liu Y, et al
    Porcine circovirus type 1 was undetected in vaccine but could be cultured in the cell substrate of Lanzhou lamb rotavirus vaccine.
    J Gen Virol. 2017 Nov 22. doi: 10.1099/jgv.0.000875.
    PubMed     Text format     Abstract available


  7. MOI ML, Ami Y, Muhammad Azami NA, Shirai K, et al
    Marmosets (Callithrix jacchus) as a non-human primate model for evaluation of candidate dengue vaccines: induction and maintenance of specific protective immunity against challenges with clinical isolates.
    J Gen Virol. 2017 Nov 21. doi: 10.1099/jgv.0.000913.
    PubMed     Text format     Abstract available


  8. DUFFY MR, Alonso-Padilla J, John L, Chandra N, et al
    Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.
    J Gen Virol. 2017 Nov 20. doi: 10.1099/jgv.0.000978.
    PubMed     Text format     Abstract available


  9. TIAN D, Sooryanarain H, Matzinger SR, Gauger PC, et al
    Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    J Gen Virol. 2017 Nov 1. doi: 10.1099/jgv.0.000964.
    PubMed     Text format     Abstract available


    October 2017
  10. MALUQUER DE MOTES C, Smith GL
    Vaccinia virus protein A49 activates Wnt signalling by targetting the E3 ligase beta-TrCP.
    J Gen Virol. 2017 Oct 17. doi: 10.1099/jgv.0.000946.
    PubMed     Text format     Abstract available


  11. SEHATA G, Sato H, Yamanaka M, Takahashi T, et al
    Substitutions at residues 300 and 389 of the VP2 capsid protein serve as the minimal determinant of attenuation for canine parvovirus vaccine strain 9985-46.
    J Gen Virol. 2017 Oct 6. doi: 10.1099/jgv.0.000936.
    PubMed     Text format     Abstract available


    September 2017
  12. CARPENTIER DCJ, Hollinshead MS, Ewles HA, Lee SA, et al
    Tagging of the vaccinia virus protein F13 with mCherry causes aberrant virion morphogenesis.
    J Gen Virol. 2017 Sep 20. doi: 10.1099/jgv.0.000917.
    PubMed     Text format     Abstract available


  13. LIU Q, Wang XF, Du C, Lin YZ, et al
    The integration of a macrophage-adapted live vaccine strain of equine infectious anaemia virus (EIAV) in the horse genome.
    J Gen Virol. 2017 Sep 7. doi: 10.1099/jgv.0.000918.
    PubMed     Text format     Abstract available


    August 2017
  14. GERNA G, Revello MG, Baldanti F, Percivalle E, et al
    The pentameric complex of human Cytomegalovirus: cell tropism, virus dissemination, immune response and vaccine development.
    J Gen Virol. 2017 Aug 15. doi: 10.1099/jgv.0.000882.
    PubMed     Text format     Abstract available


    July 2017
  15. MENON V, Ayala VI, Rangaswamy SP, Kalisz I, et al
    DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.
    J Gen Virol. 2017 Jul 31. doi: 10.1099/jgv.0.000863.
    PubMed     Text format     Abstract available


  16. KANDEIL A, Kayed A, Moatasim Y, Webby RJ, et al
    Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt.
    J Gen Virol. 2017 Jul 18. doi: 10.1099/jgv.0.000847.
    PubMed     Text format     Abstract available


  17. GODI A, Bissett SL, Miller E, Beddows S, et al
    Impact of naturally occurring variation in the human papillomavirus (HPV) 33 capsid proteins on recognition by vaccine-induced cross-neutralizing antibodies.
    J Gen Virol. 2017 Jul 8. doi: 10.1099/jgv.0.000829.
    PubMed     Text format     Abstract available


  18. SATO H, Sehata G, Okada N, Iwamoto K, et al
    Intranasal immunization with inactivated feline calicivirus particles confers robust protection against homologous virus and suppression against heterologous virus in cats.
    J Gen Virol. 2017;98:1730-1738.
    PubMed     Text format     Abstract available


    June 2017
  19. CARPENTIER DCJ, Van Loggerenberg A, Dieckmann NMG, Smith GL, et al
    Vaccinia virus egress mediated by virus protein A36 is reliant on the F12 protein.
    J Gen Virol. 2017 Jun 20. doi: 10.1099/jgv.0.000816.
    PubMed     Text format     Abstract available


  20. NAGUIB MM, Grund C, Arafa AS, Abdelwhab EM, et al
    Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not.
    J Gen Virol. 2017 Jun 5. doi: 10.1099/jgv.0.000767.
    PubMed     Text format     Abstract available


    May 2017
  21. BARATELLI M, Pedersen LE, Trebbien R, Larsen LE, et al
    Identification of cross-reacting T-cell epitopes in structural and non-structural proteins of swine and pandemic H1N1 influenza A virus strains in pigs.
    J Gen Virol. 2017 May 30. doi: 10.1099/jgv.0.000748.
    PubMed     Text format     Abstract available


  22. BARCLAY WS
    Influenza: a world of discoveries, outbreaks and controversy.
    J Gen Virol. 2017 May 23. doi: 10.1099/jgv.0.000812.
    PubMed     Text format     Abstract available


    February 2017
  23. HAINISCH EK, Abel-Reichwald H, Shafti-Keramat S, Pratscher B, et al
    Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse.
    J Gen Virol. 2017;98:230-241.
    PubMed     Text format     Abstract available


  24. YAMANAKA A, Moi ML, Takasaki T, Kurane I, et al
    Neutralizing and enhancing antibody responses to five genotypes of dengue virus type 1 (DENV-1) in DENV-1 patients.
    J Gen Virol. 2017;98:166-172.
    PubMed     Text format     Abstract available


    January 2017
  25. TOWNSEND DG, Trivedi S, Jackson RJ, Ranasinghe C, et al
    Recombinant fowlpox virus vector-based vaccines: Expression kinetics, dissemination and safety profile following intranasal delivery.
    J Gen Virol. 2017 Jan 5. doi: 10.1099/jgv.0.000702.
    PubMed     Text format     Abstract available


  26. KUZMENKO YV, Starodubova ES, Shevtsova AS, Chernokhaeva LL, et al
    Intracellular degradation and localization of NS1 of tick-borne encephalitis virus affect its protective properties.
    J Gen Virol. 2017;98:50-55.
    PubMed     Text format     Abstract available


    December 2016
  27. KUAH LF, Tang LH, Sutton T, Lim JH, et al
    Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice.
    J Gen Virol. 2016 Dec 15. doi: 10.1099/jgv.0.000683.
    PubMed     Text format     Abstract available


  28. GRANT CF, Carr BV, Singanallur NB, Morris J, et al
    The B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge.
    J Gen Virol. 2016 Dec 9:1-8. doi: 10.1099/jgv.0.000517.
    PubMed     Text format     Abstract available


  29. HAINISCH EK, Abel-Reichwald H, Shafti-Keramat S, Pratscher B, et al
    Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in the horse.
    J Gen Virol. 2016 Dec 7. doi: 10.1099/jgv.0.000673.
    PubMed     Text format     Abstract available


    November 2016
  30. WANG Z, Kedzierska L, Nuessing S, Chua B, et al
    Establishment of memory CD8+ T cells with live attenuated influenza virus (LAIV) across different vaccination doses.
    J Gen Virol. 2016 Nov 2. doi: 10.1099/jgv.0.000651.
    PubMed     Text format     Abstract available


    October 2016
  31. ZHANG Y, Zhou M, Wang Z, Yang J, et al
    Recombinant rabies virus expressing IL-21 enhances immunogenicity through activation of T follicular helper cells and germinal center B cells.
    J Gen Virol. 2016 Oct 25. doi: 10.1099/jgv.0.000646.
    PubMed     Text format     Abstract available


  32. BALL C, Bennett S, Forrester A, Ganapathy K, et al
    GENETIC MUTATIONS IN LIVE INFECTIOUS BRONCHITIS VACCINE VIRUSES FOLLOWING SINGLE OR DUAL IN VITRO INFECTION OF TRACHEAL ORGAN CULTURES.
    J Gen Virol. 2016 Oct 12. doi: 10.1099/jgv.0.000628.
    PubMed     Text format     Abstract available


    September 2016
  33. MUNIR M, Shabbir MZ, Akhtar S, Tang Y, et al
    Infectivity of Wild Bird Origin Avian Paramyxovirus Serotype 1 and Vaccine Effectiveness in Chickens.
    J Gen Virol. 2016 Sep 29. doi: 10.1099/jgv.0.000618.
    PubMed     Text format     Abstract available


  34. LI Y, Cui S, Cui Z, Chang S, et al
    Genome Analysis and Pathogenicity of Reticuloendotheliosis Virus Isolated from a Contaminated Vaccine Seed Against Infectious Bursal Disease Virus, First Report in China.
    J Gen Virol. 2016 Sep 8. doi: 10.1099/jgv.0.000588.
    PubMed     Text format     Abstract available


  35. GARCIA M, Spatz SJ, Cheng Y, Riblet SM, et al
    Attenuation and protection efficacy of ORF C gene-deleted recombinant of infectious laryngotracheitis virus.
    J Gen Virol. 2016;97:2352-62.
    PubMed     Text format     Abstract available


    August 2016
  36. BRAVO CRUZ AG, Shisler JL
    The vaccinia virus K1 ankyrin repeat protein inhibits NF-kB activation by preventing RelA acetylation.
    J Gen Virol. 2016 Aug 8. doi: 10.1099/jgv.0.000576.
    PubMed     Text format     Abstract available


  37. YUN SI, Song BH, Polejaeva IA, Davies CJ, et al
    Comparison of the live-attenuated Japanese Encephalitis vaccine SA14-14-2 strain with Its pre-attenuated virulent parent SA14 strain: Similarities and differences in vitro and in vivo.
    J Gen Virol. 2016 Aug 5. doi: 10.1099/jgv.0.000574.
    PubMed     Text format     Abstract available


    June 2016
  38. TORRES AA, Albarnaz JD, Bonjardim CA, Smith GL, et al
    Multiple Bcl-2 family immunomodulators from vaccinia virus regulate MAPK/AP-1 activation.
    J Gen Virol. 2016 Jun 16. doi: 10.1099/jgv.0.000525.
    PubMed     Text format     Abstract available


  39. SWETT-TAPIA C, Bogaert L, de Jong P, van Hoek V, et al
    Recombinant measles virus incorporating heterologous viral membrane proteins for use as vaccines.
    J Gen Virol. 2016 Jun 15. doi: 10.1099/jgv.0.000523.
    PubMed     Text format     Abstract available


  40. GRANT CF, Carr BV, Singanallur NB, Morris J, et al
    The B cell response to foot-and-mouth disease virus in cattle following vaccination and live-virus challenge.
    J Gen Virol. 2016 Jun 2. doi: 10.1099/jgv.0.000517.
    PubMed     Text format     Abstract available


    April 2016
  41. ZHAN Y, Wang N, Zhu Z, Wang Z, et al
    In silico analyses of antigenicity and surface structure variation of an emerging porcine circovirus genotype 2b mutant, prevalent in southern China from 2013 to 2015.
    J Gen Virol. 2016;97:922-33.
    PubMed     Text format     Abstract available


    February 2016
  42. MANOHARAN VK, Khattar SK, Paldurai A, Kim SH, et al
    A Y527A mutation in the fusion protein of Newcastle disease virus strain LaSota leads to a hyperfusogenic virus with increased replication and immunogenicity.
    J Gen Virol. 2016;97:287-92.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: